MiR-155 was reported to be involved in the modulation of the PIK3CA-AKT1 pathway by directly targeting the negative regulator PIK3R1 (p85α) in DLBCL cells [36]. The gene discussed is PIK3CA; the disease is diffuse large B-cell lymphoma.